Cargando…
Targeting Beta-Blocker Drug–Drug Interactions with Fibrinogen Blood Plasma Protein: A Computational and Experimental Study
In this work, one of the most prevalent polypharmacology drug–drug interaction events that occurs between two widely used beta-blocker drugs—i.e., acebutolol and propranolol—with the most abundant blood plasma fibrinogen protein was evaluated. Towards that end, molecular docking and Density Function...
Autores principales: | González-Durruthy, Michael, Concu, Riccardo, Vendrame, Laura F. Osmari, Zanella, Ivana, Ruso, Juan M., Cordeiro, M. Natália D. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699576/ https://www.ncbi.nlm.nih.gov/pubmed/33228181 http://dx.doi.org/10.3390/molecules25225425 |
Ejemplares similares
-
New Mechanistic Insights on Carbon Nanotubes’ Nanotoxicity Using Isolated Submitochondrial Particles, Molecular Docking, and Nano-QSTR Approaches
por: González-Durruthy, Michael, et al.
Publicado: (2021) -
The role of plasma concentrations and drug characteristics of beta‐blockers in fall risk of older persons
por: Ploegmakers, K. J., et al.
Publicado: (2023) -
MOZART, a QSAR Multi-Target Web-Based Tool to Predict Multiple Drug–Enzyme Interactions
por: Concu, Riccardo, et al.
Publicado: (2023) -
The evaluation of beta blocker and calcium antagonist drugs
Publicado: (1982) -
Molecular Dynamics Simulation Study of the Selectivity of a Silica Polymer for Ibuprofen
por: Concu, Riccardo, et al.
Publicado: (2016)